CORETECH 5: insider trades · France · AMF

About CORETECH 5

CORETECH 5 is a Paris-listed company traded on Euronext Access Paris under ISIN FR0013371507 and ticker MLCOT. Historically known as Gour Medical, then Coretech 5, the company now presents itself on its corporate materials as Reboost Blockchain Corp., while retaining the same market identifier. Its registered office is located in Paris at 5 rue de Castiglione, and it is incorporated in Paris under company number 833 663 172. In its 2024 financial communication, CORETECH 5 describes its core business as making equity investments in technology companies. Its website expands on this positioning by stating that the group creates, supports, and develops tech companies and blockchain protocols. In practical terms, this places CORETECH 5 in a holding-company / venture-style model rather than a traditional operating industrial business. The company’s leadership team highlights backgrounds in capital markets, corporate structuring, blockchain, crypto assets, private equity, and listed-company governance, which is consistent with an investment-led strategy. The group’s business model is therefore centered on allocating capital to early-stage or emerging technology opportunities and providing strategic support around them. The 2024 annual communication shows a very small balance sheet, with total assets of EUR 12,959.50, revenue of EUR 15,352.58, and net income of EUR 21,084.19. These figures underscore the company’s micro-cap profile and the fact that its valuation thesis is likely to depend heavily on future investments, financing capacity, and the success of portfolio initiatives rather than on recurring operating cash flows. From a market perspective, CORETECH 5 is listed on Euronext Access Paris, a segment designed for smaller issuers and typically associated with limited liquidity. Its 2024 reporting also notes PEA-PME eligibility, which may matter for French retail investors. In June 2023, the company reported 13,406,759 shares outstanding, which provides an indication of share count and potential dilution dynamics. Geographically, the company remains primarily anchored in Paris, with no recent public disclosure of a broad international operating footprint. Its notable feature is its evolving identity: a listed French micro-cap transitioning from a medical-related heritage toward a technology and blockchain-oriented investment platform. For investors and SEO readers alike, CORETECH 5 should be viewed as a niche, high-risk, high-optionalty story, where corporate strategy, capital structure, and execution quality are central to the equity case.